METTL3 and cholangiocarcinoma: Only the knockdown of METTL3 reduced SOX2 expression levels in CCA (Figure S3C), leading us to select METTL3 for methylated RNA immunoprecipitation (MeRIP)‐qPCR to measure the binding of YTHDF2 to SOX2 mRNA.